Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Grand View Research | PRODUCT CODE: 1611547

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1611547

Europe Fill Finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule, By End Use, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Europe Fill Finish Pharmaceutical Contract Manufacturing Market Growth & Trends:

The Europe fill finish pharmaceutical contract manufacturing market size is expected to reach USD 9.54 billion by 2030, expanding at a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by factors such as the increasing demand for sterile injectable drugs, the rising prevalence of chronic diseases, and the growing focus on cost containment and efficiency by pharmaceutical companies. Additionally, advancements in technology and the increasing use of contract manufacturing by pharmaceutical companies are expected to drive market growth.

The Europe fill finish pharmaceutical contract manufacturing market is also characterized by a number of trends, such as the growing importance of regulatory compliance, the increasing use of single-use technology, and the rising adoption of advanced analytical and quality control systems. Additionally, there is a growing trend towards the use of contract manufacturing by small and mid-sized pharmaceutical companies, as well as by virtual biotech companies.

Germany dominated the market in 2024 owing to a strong base of biotechnology and pharmaceutical companies in the region. These companies are involved in drug discovery activities, which, in turn, led to the growth of the market in the region. The COVID-19 pandemic has had a significant impact, and one of the major impacts of the pandemic on the fill-finish contract manufacturing market in Europe has been an increased demand for COVID-19 vaccines and therapies. This has aided in increasing the demand for CMOs in the market since the fill-finish process requires advanced technology; thus, to reduce the cost, many Pharma and Biotech companies are more focused on outsourcing the fill-finish process, thereby boosting the overall market growth.

Europe Fill Finish Pharmaceutical Contract Manufacturing Market Report Highlights:

  • On the basis of product type, Vials dominated the market and accounted for a share of 53.4% in 2024 and Prefilled syringes are expected to grow at the fastest CAGR of 9.6% over the forecast period.
  • Based on the Molecule type, the small molecule segment dominated the market in 2022 with the largest share of 67.3% in 2024 and is anticipated to show lucrative growth over the forecast period.
  • Based on the End-use segment, the biopharmaceutical segment dominated the market and accounted for the largest revenue share of 35.9% in 2024. The increasing demand for biologics and biosimilars is driving the growth of the biopharmaceutical end-use segment. Due to the market for biologics and biosimilars experiencing rapid expansion, biopharmaceutical companies are the main consumers of fill-finish contract manufacturing services.
  • The UK fill-finish pharmaceutical contract manufacturing market held the largest market share of 20.3% in 2024 in the Europe market and the fill-finish pharmaceutical contract manufacturing market in Germany is expected to grow at the fastest CAGR of 11.0% over the forecast period.
Show more
Product Code: GVR-4-68040-050-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Molecule
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Europe Fill-finish Pharmaceutical Contract Manufacturing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Europe Fill-finish Pharmaceutical Contract Manufacturing Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Prefilled Syringes
    • 4.4.1. Prefilled Syringes Market, 2018 - 2030 (USD Million)
  • 4.5. Vials
    • 4.5.1. Vials Market, 2018 - 2030 (USD Million)
  • 4.6. Cartridges
    • 4.6.1. Cartridges Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Europe Fill-finish Pharmaceutical Contract Manufacturing Market: Molecule Business Analysis

  • 5.1. Molecule Market Share, 2024 & 2030
  • 5.2. Molecule Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
  • 5.4. Large Molecules
    • 5.4.1. Large Molecules Market, 2018 - 2030 (USD Million)
  • 5.5. Small Molecules
    • 5.5.1. Small Molecules Market, 2018 - 2030 (USD Million)

Chapter 6. Europe Fill-finish Pharmaceutical Contract Manufacturing Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical Companies
    • 6.5.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7. Europe Fill-finish Pharmaceutical Contract Manufacturing Market: Country Estimates & Trend Analysis by Product, Molecule, and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. UK
    • 7.4.1. Key Country Dynamics
    • 7.4.2. Regulatory Framework
    • 7.4.3. Competitive Insights
    • 7.4.4. UK Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Germany
    • 7.5.1. Key Country Dynamics
    • 7.5.2. Regulatory Framework
    • 7.5.3. Competitive Insights
    • 7.5.4. Germany Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. France
    • 7.6.1. Key Country Dynamics
    • 7.6.2. Regulatory Framework
    • 7.6.3. Competitive Insights
    • 7.6.4. France Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Italy
    • 7.7.1. Key Country Dynamics
    • 7.7.2. Regulatory Framework
    • 7.7.3. Competitive Insights
    • 7.7.4. Italy Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Spain
    • 7.8.1. Key Country Dynamics
    • 7.8.2. Regulatory Framework
    • 7.8.3. Competitive Insights
    • 7.8.4. Spain Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Norway
    • 7.9.1. Key Country Dynamics
    • 7.9.2. Regulatory Framework
    • 7.9.3. Competitive Insights
    • 7.9.4. Norway Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Denmark
    • 7.10.1. Key Country Dynamics
    • 7.10.2. Regulatory Framework
    • 7.10.3. Competitive Insights
    • 7.10.4. Denmark Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.11. Sweden
    • 7.11.1. Key Country Dynamics
    • 7.11.2. Regulatory Framework
    • 7.11.3. Competitive Insights
    • 7.11.4. Sweden Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Thermo Fisher Scientific Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Sartorius AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Boehringer Ingelheim International GmbH
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Catalent, Inc (acquired by Novo Holdings A/S)
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Societal CDMO (Recro Pharma, Inc)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Baxter
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Eurofins Scientific
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Symbiosis Pharmaceutical Services Ltd
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. MabPlex International Co. Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Recipharm AB
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Fresenius Kabi, USA LLC
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Lonza
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-050-7

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Europe fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 4 Europe fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 5 Europe fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 6 Europe fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 UK fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 8 UK fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 9 UK fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Germany fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 11 Germany fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 12 Germany fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 13 France fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 14 France fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 15 France fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Italy fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Italy fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 18 Italy fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Spain fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 20 Spain fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 21 Spain fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Norway fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 23 Norway fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 24 Norway fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Denmark fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 27 Denmark fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Sweden fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Sweden fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 30 Sweden fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Europe fill-finish pharmaceutical contract manufacturing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and molecule outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Europe fill-finish pharmaceutical contract manufacturing market dynamics
  • Fig. 13 Europe fill-finish pharmaceutical contract manufacturing market: Porter's five forces analysis
  • Fig. 14 Europe fill-finish pharmaceutical contract manufacturing market: PESTLE analysis
  • Fig. 15 Europe fill-finish pharmaceutical contract manufacturing market: Product segment dashboard
  • Fig. 16 Europe fill-finish pharmaceutical contract manufacturing market: Product market share analysis, 2024 & 2030
  • Fig. 17 Prefilled syringes market, 2018 - 2030 (USD Million)
  • Fig. 18 Vials market, 2018 - 2030 (USD Million)
  • Fig. 19 Cartridges market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Europe fill-finish pharmaceutical contract manufacturing market: Molecule segment dashboard
  • Fig. 22 Europe fill-finish pharmaceutical contract manufacturing market: Molecule market share analysis, 2024 & 2030
  • Fig. 23 Large molecules market, 2018 - 2030 (USD Million)
  • Fig. 24 Small molecules market, 2018 - 2030 (USD Million)
  • Fig. 25 Europe fill-finish pharmaceutical contract manufacturing market: End use segment dashboard
  • Fig. 26 Europe fill-finish pharmaceutical contract manufacturing market: End use market share analysis, 2024 & 2030
  • Fig. 27 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe fill-finish pharmaceutical contract manufacturing market revenue, by country
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 UK fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 33 Germany country dynamics
  • Fig. 34 Germany fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 35 France country dynamics
  • Fig. 36 France fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 37 Italy country dynamics
  • Fig. 38 Italy fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain country dynamics
  • Fig. 40 Spain fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 Norway country dynamics
  • Fig. 42 Norway fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden country dynamics
  • Fig. 44 Sweden fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark country dynamics
  • Fig. 46 Denmark fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 47 Company categorization
  • Fig. 48 Company market position analysis
  • Fig. 49 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!